VEILTA
10/31/2026
Korea exports the finished brand. China exports the factory behind it. That single sentence explains most of what follows, and it is why "which is better" is the wrong question to start with.
If you are weighing manufacturers rather than reading for background, the full-service OEM/ODM page sets out how development runs — brief to sample, MOQ per format and the documentation we hold.
Korean ODMs built their reputation on formula innovation for a market that rewards novelty every season. Chinese manufacturers built theirs on volume, packaging integration and delivery reliability for buyers who already know what they want made. A brand choosing between them is not choosing quality; it is choosing which constraint it can live with.
This comparison covers where each side genuinely wins, the MOQ and tooling differences that decide first orders, and the certification questions that matter more than either country's reputation.
Formula novelty. Korea's domestic market turns over faster than any other in skincare. An ODM serving that market has to produce new textures and actives on a seasonal cadence, and that pressure produces formulations that are genuinely ahead on sensory finish and trend timing.
Small-batch agility. Korean ODMs are set up to serve many small brands, and their minimums reflect that. If your launch is a 3,000-unit test in one channel, Korea is often the easier conversation.
Brand-side familiarity. Korean ODMs routinely work with founders who have no manufacturing background and structure their process around that. If you have never approved a die line or read a batch COA, the hand-holding is real value.
Marketing provenance. "Made in Korea" still carries a premium in several categories, and no amount of specification quality in a Chinese quote changes what the label says.
Packaging integration. A Chinese factory that makes the patch and prints the pouch in the same building removes an entire supply step, and every removed step removes a failure mode. Misaligned artwork, mismatched seal width and the classic "pouch arrived two weeks after the product" all disappear.
Substrate and format breadth. Spunlace, cupro, Tencel, cotton, bio-cellulose, hydrogel, hydrocolloid, microneedle and silicone are all stock categories for a Guangdong plant serving export buyers. A single factory can quote sheet masks, eye patches and acne patches from the same production base.
Delivery reliability at volume. Bulk production in 20–25 working days after artwork approval, with in-house filling and sealing, is achievable because the line is not shared with a dozen small seasonal runs.
Cost structure on mature formats. Once a format is standardised, the Chinese cost base is hard to match. This is why the sheet masks sold under Korean brand names are frequently manufactured outside Korea.
That last point is worth sitting with. Origin labelling follows the country of manufacture, not the country of the brand's marketing story. Buyers who assume a Korean brand implies a Korean factory are often wrong.
China-side minimums for the formats we run:
| Format | Minimum order | Printed packaging adds |
|---|---|---|
| Sheet mask | 5,000 pcs per formula | +5,000 pcs per design |
| Under-eye patch | 3,000 pairs | +5,000 pcs per design |
| Hydrocolloid acne patch | 10,000 pcs per size | +5,000 pcs per printed pouch |
| Custom die | +5,000 pcs | — |
| Bespoke formula | +5,000 pcs, plus formulation fee | — |
Korean minimums vary more widely by ODM and by whether you accept a stock formula. Do not accept a verbal figure. Ask for the minimum on the exact format you need, in writing, and ask separately what a printed pouch does to it. That second number is the one that surprises buyers in both countries.
The comparison that actually matters is not "5,000 vs 3,000". It is total first-order cost divided by sellable units, at the volume you can realistically sell. A lower minimum at a higher unit price can be the more expensive decision.
Both countries can supply ISO 22716, GMP and the documentation set for an EU CPSR. The differences are in what each side treats as standard versus special order.
We supply full INCI, batch COA, SDS/MSDS, stability data, microbial reports and the inputs a safety assessor needs for an EU CPSR, as part of the standard documentation set. The CPSR itself is issued by a qualified assessor, not by the factory, in either country.
Where Chinese manufacturers differ is Halal and FDA registration, which are standard for export-oriented plants serving the Middle East and US markets. Ask any supplier, in either country, for the certificate number rather than the certificate name. A logo on a website is not evidence.
Three questions sort real capability from marketing:
The third question is the one that reveals whether a supplier has actually been through a market rejection.
Answer these four in order. The answer usually falls out.
How many units can you sell in the first six months? Below 5,000, Korea is often the more practical route because minimums and hand-holding are built for it. Above 5,000, the Chinese cost and integration advantages start to dominate.
Does your product need packaging innovation? Printed pouch, unusual pack structure, custom die, secondary carton with insert. The more packaging complexity, the more a single-site factory wins, because every outsourced step is a coordination cost you absorb.
Is the brand story dependent on provenance? If "Korean formula" is on the packaging, the honest route is Korea. If the story is formulation performance, sourcing should follow cost and capability, not geography.
How much process can you absorb? Korean ODMs absorb more of it for you. Chinese factories assume a buyer who knows what a die line is. Being honest about which buyer you are saves a quarter of avoidable delay.
Two assumptions cause most of the damage.
Assuming Korea means small and China means cheap. Neither holds at scale. Korean ODMs run large volumes, and Chinese manufacturers quote high prices for complex work. Country is a weak predictor; the specific factory's capability is a strong one.
Assuming switching later is cheap. Moving a product between manufacturers means new tooling, new stability data, a new CPSR in the EU and, usually, a reformulation because the second factory cannot match the first one's substrate. The first choice is stickier than it looks, which is why it deserves more diligence than a price comparison.
Is Korean OEM better quality than Chinese OEM? Not as a general rule. Both countries produce cosmetic products to the same international standards, and quality varies more between individual factories than between countries. What differs is what each market's factories are set up to optimise: Korea for formula novelty and small batches, China for packaging integration and volume delivery.
What is the minimum order for a Korean ODM versus a Chinese manufacturer? Chinese minimums for the formats we run are 5,000 pieces per formula for sheet masks, 3,000 pairs for under-eye patches and 10,000 pieces for hydrocolloid acne patches, with printed packaging, custom dies and bespoke formulas each adding 5,000 pieces. Korean minimums vary by ODM and by whether a stock formula is accepted, so the only reliable comparison is a written quote on your exact format.
Can a Chinese factory supply a formula that matches a Korean product? Matching a specific commercial product exactly is not possible without its formulation, and reverse-engineering a competitor's product raises legal and ethical problems. What is normal practice is developing a formula to a brief that describes the target sensory profile, texture and claim set. That is a development project, not a copy job.
Which is faster from brief to stock? Sampling from a Chinese formula library runs 5–7 working days, and bulk production 20–25 working days after artwork approval. Korean timelines depend on the ODM's queue at the time you book capacity, which is the reason to ask for a dated production slot rather than an average. Freight to your destination adds the same 25–30 days by sea from either country.
Does country of origin affect what I can claim on the label? Yes, and not in the way most buyers expect. Origin labelling follows where the product was manufactured, not where the brand is based. Claims about ingredients and efficacy are governed by the destination market's rules, not the manufacturing country, so a "Korean" formulation still has to satisfy EU or US claim rules if that is where it sells.
Tell us your format, first-order volume and destination market. We will tell you plainly whether a Chinese line is the right fit for that brief, and what the equivalent Korean route would cost you in minimums and lead time.
Send your spec — format, size, pieces per pack and destination market — and we will come back within two working days with a costed quotation on the line described above.
